Delivery Order SPE2DE23D0008-SPE2D625F2SSN
Award Date 9/5/25
Potential Completion Date 9/9/25
Potential Value $3K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed Pricing Type
Fixed Price with Economic Price Adjustment
Place of Performance
Irvine, CA 92612, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- Allergan USA Inc., a subsidiary of AbbVie Inc., was awarded a delivery order valued at $1,495.00 on September 2, 2025, for the supply of Natrelle TE Smooth 133S-MX-13-T breast implants. This fixed-price contract with economic price adjustment is funded by the Medical Supply Chain division of the Defense Logistics Agency Troop Support Medical and is scheduled for completion by September 4, 2025. The contract carries no set-aside designation, reflecting Allergan's status as a sole-source...
- Allergan USA Inc., a subsidiary of AbbVie Inc., has been awarded a delivery order valued at $1,495.00 for Natrelle TE Smooth 133S-MX-14-T breast implants. This fixed-price contract with economic price adjustment was awarded on November 20, 2025, with an ultimate completion date of November 24, 2025, and will be performed in Irvine, California. The contract was funded by the Medical Supply Chain division of the Defense Logistics Agency and carries no set-aside designation, reflecting Allergan's...
- Allergan USA Inc., a subsidiary of AbbVie Inc., has been awarded a delivery order valued at $2,990.00 for Natrelle TE Smooth 133S-MV-14-T breast implants under a fixed-price contract with economic price adjustment. The award was issued on September 11, 2025, with an ultimate completion date of September 25, 2025, and carries no set-aside designation, reflecting Allergan's status as a sole-source provider of these specialized medical devices. The product will be delivered to Irvine, California,...
- Allergan USA Inc., a subsidiary of AbbVie Inc., was awarded a $1,495 fixed-price delivery order (contract number 4570063968) for Natrelle TE Smooth 133S-MV-15-T breast implants on November 20, 2025, with an ultimate completion date of November 24, 2025. The award was made without a set-aside designation and will be performed in Irvine, California. Funding is provided by the Medical Supply Chain division of the Defense Logistics Agency Troop Support Medical, which procures specialized surgical...
- Allergan USA Inc., a subsidiary of AbbVie Inc., was awarded a $1,495 fixed-price delivery order for NATRELLE TE Smooth 133S-MX-15-T breast implants on August 14, 2025, with an ultimate completion date of August 18, 2025. This contract was funded by the Medical Supply Chain division of the Defense Logistics Agency and will be performed in Irvine, California. The award carries no set-aside designation, reflecting Allergan's status as a sole-source provider of specialized breast implant...
- Allergan USA Inc., a subsidiary of AbbVie Inc., was awarded a delivery order valued at $1,495.00 for NATRELLE TE SMOOTH 133S-MV-13-T breast implants on August 21, 2025, with an ultimate completion date of September 8, 2025. This fixed-price contract with economic price adjustment is funded by the Defense Logistics Agency's Medical Supply Chain division and will be performed at Allergan's facility in Irvine, California. The award was made without any set-aside designation, reflecting Allergan's...
- Allergan USA Inc., a subsidiary of AbbVie Inc., was awarded a fixed-price delivery order valued at $3,404.00 for Natrelle TE Smooth 133S-MX-14-T breast implants on July 24, 2025. This delivery order, issued without set-aside designation, represents a child contract under Allergan's larger Indefinite Delivery Vehicle (IDV) agreements with the Defense Logistics Agency (DLA) Troop Support Medical. The contract is funded through the Medical Supply Chain division of DLA and involves fixed-price...
- Allergan USA Inc., a subsidiary of AbbVie Inc., was awarded a delivery order on September 11, 2025, by the Defense Logistics Agency's Medical Supply Chain division for 4569553905 Inspira SRF 385CC breast implants, valued at $1,110.00. This fixed-price delivery order with economic price adjustment carries an ultimate completion date of September 25, 2025, and represents performance work to be completed at Allergan's facility in Irvine, California. The award utilizes no set-aside designation,...
- Allergan USA Inc., a subsidiary of AbbVie Inc., was awarded a delivery order valued at $2,814.00 by the Defense Logistics Agency's Medical Supply Chain division on July 22, 2025, with an ultimate completion date of July 24, 2025. The contract covers the supply of Natrelle Inspira SCM 375CC breast implants and will be performed in Irvine, California. This award was made without set-aside designation, reflecting Allergan's position as a specialized supplier of these medical devices to federal...
- Allergan USA Inc., a subsidiary of AbbVie Inc., was awarded a $1,614.00 fixed-price delivery order on September 19, 2025, for Natrelle Inspira SCM 445CC breast implants through the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain. The contract carries an ultimate completion date of September 23, 2025, and will be performed in Irvine, California. This delivery order was issued without set-aside designation, reflecting Allergan's sole-source supplier status for specialized...